XTL BioPharma (XTLB.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

May1

XTL BioPharma released FY2024 Q4 earnings on April 30 (EST), actual revenue USD 405 K, actual EPS USD -0.0909

03:00

XTL BioPharma released FY2024 annual earnings on April 30 (EST), actual revenue USD 451 K, actual EPS USD -0.2999

03:00

Apr30

XTL Biopharma Reports $1.03M Net Loss in Fiscal Year 2024

20:02

Dec31

XTL BioPharma released FY2024 Q3 earnings on December 30 (EST) with actual revenue of 46 K USD and EPS of -0.1333 USD

04:00

XTL BioPharma released FY2024 Semi-Annual Earnings on December 30 (EST) with actual revenue of 0 USD and EPS of -0.0401 USD

04:00

XTL BioPharma released FY2024 9 Months Earnings on December 30 (EST), with actual revenue of 46K USD and EPS of -0.1844 USD

04:00

Schedules & Filings

Schedules

Filings

Dec24

Reverse Stock Split(EST)

1-for-4 Reverse Stock Split

Apr30

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 405 K, Net Income -255 K, EPS -0.0909

Dec30

Earning Release(EST)

FY2024 Q3 Earning Release (USD) Revenue 46 K, Net Income -553 K, EPS -0.1333

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More